Clinical Study

Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases

Table 2

Metabolic characteristics of T2DM and PCOS females in normal-weight and overweight subgroups categorized by BMI.

T2DM normal-weightT2DM overweight/obesePCOS normal-weightPCOS overweight/obese

Age (years)47.48 ± 4.8646.72 ± 5.010.58920.33 ± 5.1823.66 ± 5.650.087
BMI (kg/m2)21.90 ± 1.6427.00 ± 2.46<0.00122.24 ± 1.4428.97 ± 3.37<0.001
WHR0.83 ± 0.100.93 ± 0.07<0.0010.86 ± 0.070.91 ± 0.100.064
SBP (mmHg)122.76 ± 12.53126.56 ± 10.030.227115.27 ± 11.68119.21 ± 10.600.316
DBP (mmHg)76.48 ± 9.3377.34 ± 8.540.72971.73 ± 6.0577.79 ± 8.660.040
FBG (mmol/L)7.10 ± 1.997.84 ± 3.460.3854.27 ± 0.624.93 ± 2.600.391
FINS (mU/mL)9.08 ± 5.1511.29 ± 6.880.21611.63 ± 3.3615.85 ± 6.370.037
HbA1c (%)8.42 ± 2.729.02 ± 2.230.4055.20 ± 0.256.41 ± 1.870.003
HOMA-IR2.15 (1.26–3.17)3.14 (2.07–5.28)0.1061.61 (1.02–2.01)3.19 (2.63–4.23)0.007
HOMA-β44.05 (21.23–98.67)56.66 (30.75–87.21)0.611259.20 (181.13–368.19)158.44 (133.33–474.03)0.915
OGTT-30 min insulin (mU/mL)23.80 (11.05–30.05)17.90 (13.3–28.1)0.96040.55 (35.43–77.10)62.10 (36.40–98.00)0.231
OGTT-60 min insulin (mU/mL)21.50 (10.35–53.70)28.00 (20.90–55.35)0.49043.90 (40.75–52.00)91.40 (60.70–138.00)0.004
OGTT-120 min insulin (mU/mL)26.00 (14.15–48.30)30.60 (18.45–59.05)0.37534.30 (24.28–64.35)84.60 (57.60–179.10)0.034
OGTT-180 min insulin (mU/mL)13.50 (10.20–24.10)22.90 (13.25–35.40)0.04314.05 (5.98–27.30)55.70 (34.30–88.90)0.601
OGTT-IAUC3886.50 (2090.25–7894.50)4779.00 (3212.25–7833.00)0.3976000.75 (5749.13–8155.88)15915.00 (9030.00–21195.00)0.041
TG (mmol/L)1.83 ± 1.132.05 ± 1.240.5131.43 ± 0.741.69 ± 0.910.444
TC (mmol/L)4.66 ± 0.834.79 ± 1.020.6323.86 ± 0.644.67 ± 1.090.045
LDL-C (mmol/L)3.08 ± 0.663.25 ± 0.860.4642.44 ± 0.603.01 ± 0.810.065
HDL-C (mmol/L)1.25 ± 0.331.12 ± 0.220.1111.14 ± 0.141.23 ± 0.440.535
AST (IU/L)19.68 ± 10.8523.50 ± 15.660.35917.42 ± 4.7824.98 ± 12.710.094
ALT (IU/L)23.18 ± 13.9327.00 ± 20.490.48314.15 ± 7.0828.25 ± 18.740.002
γ-GGT (IU/L)16.10 (13.70–32.70)21.70 (15.50–34.10)0.06217.25 (12.03–29.98)29.50 (23.90–56.70)0.018
WBC (109/L)5.67 ± 1.426.36 ± 2.100.1826.43 ± 1.937.25 ± 1.530.144
CRP (mg/L)5.22 ± 0.605.53 ± 1.790.1554.71 ± 2.164.10 ± 1.900.423

Notes: Data are presented as deviation for normally distributed variables and median (interquartile range) for nonnormally distributed variables. values are from unpaired test or Mann-Whitney test. –21 normal-weight T2DM subjects, –32 overweight/obese T2DM subjects, –12 normal-weight PCOS subjects, –29 overweight/obese PCOS subjects. OGTT: oral glucose tolerance test; IAUC: insulin area under the curve.